Fiche publication
Date publication
juin 2026
Journal
Gynecologic oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr FAVIER Laure
,
Dr HOTTON Judicaël
Tous les auteurs :
Montassier T, Laas E, Hotton J, Berton-Rigaud D, Bonneau C, Fernandez Y, Guyon F, Joly F, Gauroy E, Ray-Coquard I, Perrin M, Favier L, Vegas H, Emambux S, Dorri NM, Madad-Zadeh S, Gouy S, Lecuru F, Paoletti X, Gaillard T
Lien Pubmed
Résumé
In high-grade serous ovarian carcinoma (HGSOC), time to first recurrence is a major prognostic factor guiding therapeutic management. However, this parameter remains poorly studied in low-grade serous ovarian carcinoma (LGSOC), a rare subtype characterized by indolent progression and marked chemoresistance. Moreover, AGO criteria for selecting candidates for secondary cytoreductive surgery appear poorly applicable to LGSOC, highlighting the need for specific prognostic markers.
Mots clés
Low-grade serous ovarian carcinoma, Post-relapse progression-free survival, Post-relapse survival, Prognostic factor, Time to recurrence
Référence
Gynecol Oncol. 2026 06 26;211:59-66
